Genotype-drive Study of Irinotecan-Cisplatin Combination for Advanced Gastric Cancer
Status:
Completed
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of first-line chemotherapy
with cisplatin and irinotecan in advanced gastric cancer, and try to find out the optimal
dosage of combination chemotherapy.